Obesity Care

Obesity and high-fat diets linked to swift vascular ageing in the brain

A new study conducted in mice traces how obesity and a high-fat diet may accelerate ageing in the blood vessels that supply blood to the brain. The work is being presented this week at the American Physiology Summit, the flagship annual meeting of the American Physiological Society (APS), in Long Beach, California. 

The findings suggest that obesity and a poor diet can cause damage to accumulate in the blood vessels, reducing the supply of oxygen to parts of the brain and ultimately leading to cognitive decline. The study could help scientists find ways to intervene and preserve brain function in people with obesity, which is estimated to affect about 42% of U.S. adults. 

“This project highlights the critical roles of vascular components and cellular ageing in cognitive deterioration, pinpointing novel potential therapeutic targets for dementia prevention and treatment,” said Sharon Negri, PhD, the study’s first author and a postdoctoral research fellow in the laboratory of Stefano Tarantini, PhD, in the Department of Neurosurgery at the University of Oklahoma Health Sciences Center. 

Previous research has found strong links between mid-life obesity and an increased risk of cognitive decline and dementia later in life. The scientists sought to uncover the mechanisms behind this association, with a particular focus on the role of diet and vascular health. 

To do this, the researchers studied the impact of a high-fat diet on blood flow to the brain and memory performance in aged mice with obesity. By using a special mouse model, they were also able to measure cellular senescence, a process when cells stop dividing and making new cells. Cellular senescence increases with ageing and contributes to a variety of ageing-associated diseases. 

“Obesity may cause the cells in blood vessels in the brain to age faster and reach senescence. If a link between obesity and cellular senescence is established, it could open up new lines of investigation aimed at exploring therapeutic avenues to prevent or slow down the progression of senescence, with the potential to mitigate obesity-related health issues, including cognitive decline.” – Sharon Negri, PhD, study’s first author

The results showed that after three months, mice fed a high-fat diet had increased cellular senescence and reduced density of healthy blood vessels in the brain, as well as evidence of impaired learning in a maze test, compared with normal-weight mice fed a standard diet. In addition, the scientists found that removing the senescent cells using Navitoclax, an investigational cancer drug that selectively kills senescent cells, improved features of the brain vasculature. 

If further experiments confirm that it is possible to reverse the detrimental effects of senescence, Negri and Tarantini next plan to evaluate whether various lifestyle interventions could help to prevent or reduce obesity-induced cognitive impairment.

Revolutionising obesity treatment with new gender-specific microbiome findings

Recent investigations to be unveiled at the European Congress on Obesity (ECO) held in Venice, Italy, from the 12th to the 15th of May, 2024, have shed light on the pivotal role that variations in gut microbiota composition play in the genesis and evolution of obesity, revealing notable distinctions between genders. This differentiation may significantly influence the metabolism of various nutrients, thereby affecting the presence of bioactive molecules within the gut that are crucial in the progression of metabolic diseases.

The gut microbiota encompasses a complex consortium of microorganisms, including bacteria, viruses, fungi, and protozoa, that reside within the gastrointestinal tract. A state of imbalance within this microbial community, known as dysbiosis, has profound effects on metabolic health, altering the risk of developing diseases such as obesity. Yet, the specific microbial species that contribute to a higher or lower risk of obesity and their exact impact on metabolic health remain subjects of ongoing research.

In an effort to deepen understanding of the role these microorganisms play in obesity, researchers conducted an analysis of metagenomic and metabolomic data from a Spanish cohort. This analysis aimed to decipher the mechanisms through which gut microbes contribute to obesity’s development.

The study involved examining the faecal metabolome—the vast array of metabolites found in the gut and excreted in faeces, produced by gut bacteria as they metabolise food. These metabolites enter the bloodstream, where they can have significant health impacts.

A total of 361 adults (251 women and 110 men, with a median age of 44 years) from the Spanish Obekit study—a randomised trial exploring the relationship between genetic variants and responses to a hypocaloric diet—were included in the analysis. Participants were categorised based on their obesity (OB) index into LOW (BMI ≤ 30 kg/m²; fat mass percentage ≤ 25% for women or ≤ 32% for men; waist circumference ≤ 88 cm for women or ≤ 102 cm for men) or HIGH (BMI > 30 kg/m²; fat mass > 25% for women or > 32% for men; waist circumference > 88 cm for women or > 102 cm for men) obesity levels. This grouping ensured a balanced representation of sexes and ages within each category.

Microbiota profiling through genetic analysis was employed to ascertain the diversity, composition, and relative abundance of bacteria in participants’ stool samples.

Key findings indicated that individuals with a HIGH OB index displayed significantly reduced levels of Christensenella minuta—a bacterium associated with leanness and health. In men, an increased presence of Parabacteroides helcogenes and Campylobacter canadensis was strongly linked to elevated BMI, fat mass, and waist circumference. Conversely, in women, a higher abundance of Prevotella micans, Prevotella brevis, and Prevotella sacharolitica was strongly indicative of increased BMI, fat mass, and waist circumference, but these associations were not observed in men.

Further analyses, examining a broader spectrum of metabolic compounds in the blood, identified variations in certain metabolites, particularly elevated levels of bioactive lipids—phospholipids and sphingolipids—which are implicated in metabolic disease development and are key modulators of insulin sensitivity and contributors to diabetes and vascular complications in individuals with a HIGH OB index.

Dr. Paula Aranaz, the study’s lead author from the Centre for Nutrition Research at the University of Navarra in Spain, explained, “Our findings underscore the significant role of bacterial imbalance in the onset and progression of obesity, highlighting notable differences between genders. This imbalance affects the metabolism of bioactive molecules in the metabolome, which in turn influences metabolic disease development.”

Dr. Aranaz further elaborated on the protective role of the Christensenella minuta bacterium against obesity and noted that the microbial species influencing obesity risk differ by sex. This necessitates gender-specific interventions to prevent an obesity-promoting microbiome. She emphasised the need for additional research to pinpoint when the shift to an obesity-favourable gut microbiota occurs, to better time potential interventions.

She concluded with optimism, stating, “This study demonstrates the utility of combining metagenomics with metabolomics to unravel the mechanisms at play in metabolic disease development, such as obesity. This innovative, comprehensive approach has the potential to foster the creation of nutritionally precise strategies for weight management that alter specific bacterial strains or bioactive molecule levels.”

However, the authors acknowledged certain limitations of their study, including its relatively small sample size—particularly for men—and its geographical limitation to one region in Spain. Given that factors such as climate, geography, diet, and culture can influence the gut microbiome, the applicability of these findings to other populations may be limited.

Healthcare professionals struggle to tackle childhood obesity due to insufficient training

In the face of the escalating childhood obesity crisis, healthcare professionals are encountering significant hurdles, primarily due to a glaring deficiency in training and operational bandwidth. This predicament was illuminated through a study published in the British Journal of General Practice, wherein researchers from the University of Birmingham conducted thorough interviews with healthcare professionals (HCPs) to delve into their experiences with aiding families in the battle against childhood obesity.

One revealing testimony from the study highlighted the practical challenges faced by HCPs: “I had one mum and her child was overweight, but she was a young parent and she actually didn’t know how to cook the dinners and, yeah… we spent a lot of time with her giving her worksheets, how to cook, make potato and beans rather than going to the fish and chip shop.” This account underscores the multifaceted nature of the obesity issue, which extends beyond medical intervention to encompass educational and lifestyle components.

The research unearthed several themes that have frustrated healthcare professionals in their efforts to support families. Among these was the constrained time and training available to HCPs, compounded by a scarcity of specialist services and limited access to routinely collected data on children’s weight. A poignant concern was the risk of eroding trust by broaching the sensitive subject of weight, alongside the need to navigate cultural sensitivities carefully.

Miranda Pallan, Professor of Child and Adolescent Public Health at the University of Birmingham and senior author of the paper, brought to light the pressures faced by healthcare professionals. “This study brings a fresh awareness about the pressures that healthcare professionals face, including the limitations that they face in trying to provide preventative care for young people,” she remarked, emphasising the barriers to offering effective guidance and support.

Echoing these concerns, Dr Ellen Fallows, a sessional GP with a keen interest in childhood obesity, noted a pervasive reluctance to address the root causes, primarily due to a lack of time, knowledge, and incentives among healthcare professionals. “Everyone thinks it is everyone else’s problem, no one is actually talking about the root causes with parents – which is predominantly food quality,” Dr Fallows observed. She advocated for the wider availability of quality training resources as a vital first step in equipping HCPs to tackle this issue.

The study also touched upon the contentious use of BMI centiles for assessing children’s weight issues, revealing a division among healthcare professionals. Some, including doctors and primary care nurses, admitted to being less familiar with BMI centiles and questioned its suitability for younger children. One participant noted, “We used to use the [height and weight] centile charts and actually the BMI will put a lot more children in an overweight category than the centile charts will.”

The collective insights from this study underscore a pressing need for a strategic overhaul in how childhood obesity is approached within the healthcare system. While the direct teaching of nutritious cooking to families might be beyond the scope of HCPs, the findings advocate for an enhanced support framework, enabling practical advice and referrals to specialist services. As childhood obesity continues to pose a serious, multifaceted challenge, the call for a comprehensive strategy that includes better training, resources, and a unified effort to address its root causes has never been more urgent.

Study reveals sweeteners do not elevate hunger while aiding in blood sugar reduction

In a groundbreaking research endeavour, the substitution of sugar with both artificial and natural sweeteners has been shown to not increase hunger levels in individuals, whilst also facilitating a reduction in blood sugar levels. This discovery comes from a rigorous double-blind randomised controlled trial, which observed that foods containing sweeteners do not lead to heightened appetite sensations or alter appetite-related hormone reactions compared to their sugary counterparts. Notably, this substitution offers additional advantages, such as the lowering of blood sugar levels, a crucial factor for individuals at risk of developing type 2 diabetes.

The incorporation of sweeteners as a sugar substitute in food products has sparked considerable debate, with prior studies providing inconclusive evidence regarding their potential to stimulate appetite. However, this recent study, adhering to the highest standards of scientific proof, delivers compelling evidence that sweeteners and sweetness enhancers do not adversely affect appetite. Moreover, they play a significant role in reducing sugar intake.

Conducted under the auspices of the University of Leeds in collaboration with the Rhône-Alpes Research Center for Human Nutrition, this study forms part of the extensive research undertaken by the SWEET consortium. Comprising 29 European partners from research, consumer, and industry sectors, the consortium aims to investigate the long-term benefits and possible risks associated with the transition to sweeteners and sweetness enhancers, focusing on public health and safety, obesity, and sustainability. The research received funding from Horizon Europe.

Catherine Gibbons, the study’s lead author and an Associate Professor at the University of Leeds’ School of Psychology, stressed the importance of reducing sugar intake in combating the escalating prevalence of obesity-related metabolic diseases like type 2 diabetes. She noted that removing sugar from foods without offering a substitute could potentially compromise taste and heighten cravings for sweet foods, thus making adherence to a low-sugar diet challenging. The substitution of sugars with sweeteners and sweetness enhancers in food products represents a prevalent dietary and food manufacturing strategy to diminish sugar consumption and enhance the nutritional value of commercial foods and beverages.

Graham Finlayson, Principal Investigator and Professor of Psychobiology at the University of Leeds, highlighted the scrutiny that the use of sweeteners and sweetness enhancers has attracted, including claims linking their consumption to adverse health outcomes. These reports have muddled public perception, particularly among those at risk of metabolic diseases, about the safety of these substances.

“Our study provides essential evidence supporting the daily use of sweeteners and sweetness enhancers in managing body weight and blood sugar levels,” Finlayson stated.

This pioneering study, a first of its kind, examined the impact of consuming biscuits infused with either sugar, the natural sugar alternative Stevia, or the artificial sweetener Neotame on a group of 53 adult men and women with overweight or obesity issues. Prior research on sweeteners and sweetness enhancers predominantly utilised beverages as a medium and seldom included participants with overweight or obesity or both sexes. Moreover, these studies usually focused on a single sweetener, primarily aspartame, against a control, with very few examining the effects of repeated daily consumption of a known sweetener or sweetness enhancer as part of a regular diet.

The trial, executed at the University of Leeds and the Rhône-Alpes Research Center for Human Nutrition in France between 2021 and 2022, involved participants aged between 18 to 60, all with overweight or obesity. It comprised three two-week consumption phases, with participants consuming biscuits containing different fillings: sugar, Stevia, or Neotame, with intervals of 14-21 days between each phase.

The initial and final days of these phases were conducted in a laboratory setting. Participants, after an overnight fast, provided blood samples to establish baseline glucose, insulin, and appetite-related hormone levels. They were also asked to evaluate their hunger and food preferences. Following the biscuit consumption, participants rated their fullness over several hours, and measurements were taken for glucose and insulin levels, along with ghrelin, glucagon-like peptide 1, and pancreatic polypeptide – hormones linked to food consumption.

The findings indicated no significant differences in appetite or endocrine responses between the sweetener types and sugar. However, insulin levels, measured two hours post-consumption, along with blood sugar levels, were observed to decrease.

Professor Anne Raben, joint co-ordinator of the SWEET project from the University of Copenhagen, Denmark, remarked, “The findings affirm that sweeteners are a beneficial tool in reducing the consumption of added sugar without triggering a compensatory increase in hunger or energy intake. This supports the effectiveness of sweeteners in managing appetite, energy, and weight.”

Obesity during youth could double the risk of multiple sclerosis in later life, research suggests

Children grappling with obesity might face a significantly higher likelihood of being diagnosed with multiple sclerosis (MS) in adulthood, according to recent research findings.

Multiple sclerosis is a condition that impacts the brain and spinal cord, leading to a wide array of potential symptoms, including challenges with vision, coordination in the arms or legs, sensation, or balance. As a lifelong affliction, MS can sometimes lead to severe disability.

These insights are set to be shared at the European Congress on Obesity, taking place in Venice this May, and stem from research conducted by the Karolinska Institute in Stockholm.

Prior studies have hinted at a connection between an elevated body mass index (BMI) during adolescence and a heightened risk of MS. However, the majority of these analyses relied on retrospective approaches and self-reported data, which could introduce biases.

The recent investigation aimed to prospectively assess the risk of MS development among a significant cohort of children with obesity in comparison to their counterparts in the broader population. To this end, the researchers turned to the Swedish Childhood Obesity Treatment Register, also known as Boris. This database stands as one of the globe’s most extensive records dedicated to the treatment of childhood obesity.

The team reviewed data pertaining to children between the ages of two and 19 who were enrolled in the registry from 1995 to 2020. This information was then juxtaposed with data from the general population of children.

In total, the study took into account data from over 21,600 children who commenced obesity treatment at an average age of 11, alongside more than 100,000 children without obesity.

Throughout an average tracking period of six years, MS was diagnosed in 28 children from the group with obesity (representing 0.13% of this cohort) and 58 children from the group without obesity (0.06%).

The average age at which MS was diagnosed remained similar across both groups, with diagnoses typically occurring around the age of 23.

While acknowledging certain limitations in their study, the researchers underscored: “Despite the limited follow-up time, our findings accentuate that childhood obesity amplifies the risk of developing early-onset MS by more than double.”

The study’s lead researchers, Associate Professor Emilia Hagman and Professor Claude Marcus, commented: “Obesity during childhood induces a low-grade, yet chronic inflammation, which likely elevates the risk of developing various conditions, including MS.”

They further elucidated that such chronic low-grade inflammation is believed to elevate the risk of other conditions, such as asthma, arthritis, type 1 diabetes, and certain cancers. Notably, they highlighted that weight loss can diminish inflammation, thereby potentially reducing the risk of developing these diseases.

Very low calorie diets safe for teens with obesity when monitored by a dietitian, study finds

In recent findings set to be unveiled at the European Congress on Obesity (ECO) in 2024, researchers assert that stringent low-calorie diets, when under the vigilant oversight of seasoned dietitians, hold promise for adolescents grappling with moderate to severe obesity.

The study, originating from Australia, explored the viability and tolerance of very low energy diets (VLEDs) among teenagers, revealing an overall positive reception despite some experiencing adverse effects. VLEDs, characterised by a daily intake of 800 calories or less through specialised meal replacements like bars and shakes, aim to fulfil essential nutrient needs while offering an alternative path to weight loss. This approach is particularly geared towards young individuals who have found little success with traditional diet and exercise regimens, presenting a potential prelude to a more balanced diet without resorting to bariatric surgery.

Historically, the application of VLEDs in youth has been approached with caution due to scant data concerning potential side effects—ranging from headaches and fatigue to muscle cramps and digestive issues—and their impact on overall growth, cardiac health, and psychological well-being. This hesitancy underscores the significance of the study conducted by Dr. Megan Gow and her team at the Children’s Hospital Westmead Clinical School, affiliated with The University of Sydney, Westmead, Australia.

The research delves into the initial phase of the “Fast Track to Health” study, specifically the first four weeks during which participants engaged in a nutritionally balanced VLED to initiate weight loss. The cohort, comprising 141 adolescents aged 13 to 17 years with obesity and at least one obesity-related complication (e.g., hypertension, insulin resistance, or dyslipidemia), was divided to receive either four Optifast meal replacement products daily alongside low carbohydrate vegetables and a teaspoon of vegetable oil or a similar regimen with three meal replacements and one solid meal of lean meat and vegetables.

Support was provided through weekly consultations with a dietitian, with assessments at baseline, weekly intervals, and a comprehensive survey to gauge the diet’s acceptability, detailing aspects the participants found favourable or unfavourable.

Despite prevalent side effects, the adherence rate was notably high, with an average weight loss of 5.5kg observed across participants. The majority reported experiencing multiple side effects, including hunger, fatigue, headaches, and gastrointestinal disturbances, with the incidence peaking in the first week. Interestingly, a correlation was observed between the early onset of side effects and more substantial weight loss, hinting at higher compliance with the dietary restrictions.

Feedback on the VLED’s practicality and enjoyment yielded mixed reviews, with the structured nature and the tangible outcomes of weight loss cited as positives, whereas the restrictive diet and the palatability of meal replacements drew criticism.

The findings advocate for the short-term safety and potential acceptability of VLEDs under professional guidance for adolescents with significant obesity challenges. Dr. Gow emphasises the necessity for further research to pinpoint those who would benefit most from this approach. She advocates for the incorporation of VLEDs into clinical guidelines for managing severe obesity and related health issues in young people, positioning it as a preliminary step before considering medication or surgery.

Adolescents and their guardians are encouraged to consult healthcare professionals to explore suitable treatment avenues for obesity.

This study not only sheds light on the pragmatic aspects of implementing VLEDs among adolescents but also underscores the importance of professional oversight and the need for a broader discourse on obesity management in younger populations.

BMI found outdated for childhood obesity measurement in Bristol study

A groundbreaking study hailing from Bristol has shed new light on the efficacy of current methods used to assess childhood obesity, proposing a shift towards a more precise alternative. This research scrutinises the longstanding reliance on Body Mass Index (BMI) for evaluating obesity in children, suggesting that the waist-to-height ratio (WHtR) could serve as a superior metric.

The comprehensive analysis spanned over 15 years and delved into the health metrics of 7,237 children, each nine years of age, revealing significant insights. These findings challenge the existing guidelines that favour BMI as the standard obesity measure, underlining the urgent need for more accurate obesity detection in paediatric health.

Published in the prestigious journal Paediatric Research, this study is a component of the expansive Children of the 90s project, drawing attention to the escalating obesity rates amongst 10 and 11-year-olds in England, a surge notably exacerbated by the Covid pandemic and yet to recede to pre-pandemic figures.

Professor Julian Hamilton-Shield, a consultant paediatrician at the Bristol Royal Hospital for Children and a leading figure in the study, voiced concerns over the increasing prevalence of severe obesity and its complications observed in his weight management clinic. “The uptick in severe obesity levels and its attendant severe complications underscores the necessity for reliable measures that offer a clearer insight into an individual’s health status,” stated Prof Hamilton-Shield.

The research team scrutinised BMI data sourced from the government’s National Child Measurement Programme, which annually assesses approximately a million Year 6 students across England. While BMI has been a cornerstone in determining healthy weight parameters, offering a simple and quick assessment method based on height and weight, its limitations are becoming increasingly apparent. Specifically, BMI fails to account for body frame variations or muscle mass, rendering it an incomplete measure of body fat.

This limitation is particularly poignant when considering that BMI might categorise individuals with significant muscle mass, such as rugby players, as having obesity, highlighting its outdated nature. In contrast, the study, conducted in collaboration with researchers from the University of Bristol, the University of Exeter, and the University of Eastern Finland, advocates for the WHtR as a viable replacement for BMI. This method promises a more accurate assessment of excess fat mass in children and adolescents.

Professor Andrew Agbaje, the lead author of the study, emphasised the practicality and effectiveness of the waist circumference-to-height ratio. “Utilising just a measuring tape, we can accurately identify eight out of ten children who genuinely have obesity. Furthermore, this method allows us to correctly recognise 93 out of 100 individuals who, despite being muscular, would be mistakenly classified as overweight or having obesity by BMI standards,” Prof Agbaje explained.

He further highlighted that unlike BMI, which fluctuates with age and sex, the waist-to-height ratio remains consistent, irrespective of these variables. This finding underscores the potential of WHtR to revolutionise how childhood obesity is measured, offering a more nuanced understanding of body composition and facilitating the identification of true obesity, thus enabling more targeted and effective interventions.

Study highlights higher incidence of musculoskeletal issues in young girls with obesity

Recent research indicates a concerning trend among young girls aged 4 to 11 who are overweight or have obesity, showing they are more frequently visiting GPs for musculoskeletal problems compared to their counterparts of a healthy weight.

The study reveals that girls in their first year of school (reception year) with a Body Mass Index (BMI) classified as overweight have a 24% increased likelihood of attending a GP appointment for a musculoskeletal issue at least once. This probability soars to 67% for girls identified as living with obesity. Furthermore, by the time they reach year 6, girls with obesity are 20% more likely to consult a GP for similar problems. Conversely, boys in the same age bracket with a BMI categorised as underweight were found to be 61% less likely to seek such medical advice compared to their peers of a normal weight.

The most frequently reported problems were related to knee and back pain, as outlined in the results published in the “Archives of Disease in Childhood” journal, focusing on a specific London area.

Nicola Firman, the study’s lead author and a health data scientist at Queen Mary University of London, emphasised the scarcity of longitudinal studies examining the link between obesity and musculoskeletal health outcomes during childhood. Despite a systematic review revealing a general lack of substantial evidence, this study aims to bridge that gap by investigating these health outcomes in an ethnically diverse population within the UK, known for its high rates of childhood obesity and social deprivation.

Among the youngest participants, knee pain was reported by 46% of boys and 41.5% of girls, with these figures slightly decreasing among year 6 students to 40.4% for boys and 36% for girls. In terms of back pain, 22% of reception year boys and a higher 32% of girls experienced this issue, which increased to 30% for boys and an alarming 45% for girls by year 6.

Interestingly, the study noted that reception year girls with obesity were significantly more inclined to consult their GP over musculoskeletal issues than their healthy weight female peers, a trend not observed among boys.

Firman also referenced studies from Spain and the USA, noting an observed rise in back pain incidents among girls, not boys, highlighting the global need for more longitudinal research to fully understand the relationship between childhood obesity and musculoskeletal health.

The research sample included primary school children from four ethnically diverse local authorities in north-east London.
Katharine Jenner, Director of the Obesity Health Alliance, responded to these findings with concern, stressing that primary school-aged children should be enjoying their youth actively rather than facing the physical limitations and pains leading to GP consultations. She criticised the government’s lack of action on its obesity strategy, pointing out that the goal to halve childhood obesity by 2030 is becoming increasingly unattainable without significant policy changes and implementations. 

Research indicates higher likelihood of midlife obesity in individuals whose parents had obesity

 In the midst of growing concerns regarding global health, a pivotal study poised for presentation at the esteemed European Congress on Obesity (ECO) in Venice, from 12th to 15th May 2024, sheds light on the intergenerational transmission of obesity, revealing profound insights into how parental obesity significantly influences the likelihood of obesity in their offspring during middle age.

This groundbreaking research, led by Mari Mikkelsen from the Department of Community Medicine at UiT Arctic University of Norway in Tromsø, embarks on a novel investigation into the persistence of obesity from one generation to the next, particularly extending beyond adolescence and well into adulthood—a period often overlooked in previous studies. Mikkelsen’s team delved into the intricate relationship between the Body Mass Index (BMI) of parents and their adult children, employing data meticulously gathered from the Tromsø Study, a comprehensive, ongoing population-based health study.

The analysis encompassed 2,068 parent-offspring trios, focusing on individuals aged 40-59 years who participated in the seventh wave (2015-2016) of the Tromsø Study, with their parents’ data drawn from the fourth wave (1994-1995). The findings illuminate a compelling correlation between the BMI of parents in their middle years and that of their children at a similar stage in life, underscoring a pronounced genetic and environmental legacy of obesity.

Specifically, the study reveals that when both parents had a BMI indicating obesity (BMI ≥ 30 kg/m²) during their forties and fifties, their offspring were six times more likely to experience obesity at the same age compared to those whose parents were within a normal weight range (BMI 18.5-24.9 kg/m²). Moreover, the presence of obesity in just one parent still significantly elevated the likelihood of the offspring living with obesity, with the odds being over three times higher.

An intriguing aspect of the research was the quantification of the BMI transmission effect: an offspring’s BMI increased by 0.8 units for each 4-unit rise in the mother’s BMI and by 0.74 units for every 3.1-unit increase in the father’s BMI. These findings persisted even after adjustments for several variables, including the sex, age, education, and physical activity levels of both parents and offspring.

Mikkelsen’s team provides a nuanced understanding of the multifaceted factors contributing to this familial trend in obesity. Genetic predispositions play a crucial role by influencing susceptibility to weight gain and shaping reactions to an increasingly obesogenic environment. Additionally, shared family behaviours concerning diet and exercise, established during childhood and adolescence, may further perpetuate similar BMI statuses within families.

This profound research not only reinforces the enduring impact of familial obesity patterns but also emphasises the critical need for effective obesity prevention and treatment strategies. By highlighting the long-lasting consequences of parental obesity on their children into middle age, the study paves the way for future research aimed at identifying and mitigating the factors responsible for the intergenerational transmission of obesity. In doing so, it offers hope for breaking the cycle of obesity and fostering a healthier future for subsequent generations.

Definitive link between obesity and deteriorating mental health, particularly for women, uncovered

A recent comprehensive investigation, published in the esteemed journal PLOS ONE, unveils a concerning correlation between increased body mass index (BMI) and adverse mental health outcomes, such as heightened depression and diminished well-being, with this association being particularly pronounced amongst women.

Conducted by the School of Public Health at University College Cork, Ireland, the study highlights that lifestyle choices bear minimal influence on the mental health challenges associated with obesity. The research meticulously scrutinised the health records of 1,821 individuals, aged between 46 and 73, who were meticulously selected from a vast patient pool at a leading primary care facility.

The investigation meticulously evaluated the linkage between mental health indicators and obesity, employing BMI and waist-to-height ratios as primary metrics, while duly adjusting for lifestyle habits and pre-existing health conditions. Utilising the 20-item Center for Epidemiologic Studies Depression Scale alongside the World Health Organization’s Five Well-Being Index, the study embarked on a holistic approach to gauge mental health.

Participants were required to undertake an overnight fasting session prior to submitting blood samples, which were analysed for fasting glucose and glycated haemoglobin levels. In addition, measurements of height, weight, and waist circumference were conducted, facilitating precise BMI calculations.

The comprehensive health and lifestyle questionnaire completed by participants enabled researchers to meticulously analyse demographic data, lifestyle choices, and concurrent health conditions, thereby ensuring a nuanced understanding of the study’s demographic.

The findings startlingly indicated a direct association between obesity markers, such as elevated BMI and waist-to-height ratios, and increased depressive symptoms alongside lower well-being levels, with a notable disparity observed between genders, indicating a significantly more pronounced effect in women.

This revelation aligns with prior studies, reinforcing the intricate interplay between obesity, societal, and physiological factors. The stigma, discrimination, and social prejudice faced by individuals with obesity, coupled with physical ailments like joint and back pain, are identified as potential catalysts for depressive symptoms.

Experts, including Dr. Eva Panigrahi from The Ohio State University Wexner Medical Center, who was not involved in the study, underscore the biological nexus between obesity and depression. Dr. Panigrahi elaborates on the cyclical nature of this relationship, exacerbated by a myriad of physiological and psychopathological factors, further complicating the clinical picture.

The research advocates for targeted interventions aimed at mitigating depression through effective weight management strategies at the community level, underpinning the intricate relationship long observed between obesity and depression.

Dr. Mir Ali of the MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in California, echoes the sentiment that the interconnection between obesity and mental health is multifaceted, highlighting the persistent societal stigma and discrimination against those with obesity despite advancements in understanding its complexities.

The study also sheds light on the therapeutic potential of certain antidepressants that do not provoke weight gain, such as bupropion, and the efficacy of evidence-based psychotherapies like cognitive behavioural therapy (CBT) in treating depression and managing weight concurrently.

Key strengths of this investigation include the utilisation of validated depression and well-being scales, dual indexes for measuring adiposity, and equitable gender representation among participants. However, its limitation lies in the homogeneity of the study sample, predominantly European-Caucasian from a single primary care centre, potentially limiting the generalisability of the findings.

Furthermore, Dr. Panigrahi critiques the cross-sectional design of the study, which restricts the ability to establish causal relationships, a common challenge in observational research that gathers data at a single point in time. This limitation underscores the necessity for longitudinal studies to further elucidate the intricate dynamics between obesity and mental health, particularly across diverse populations.

Study indicates significant benefits from obesity care, though few receive it

Obesity represents a significant global health challenge, marked by its complex aetiology and the substantial health risks it poses. Effective management of obesity can dramatically improve health outcomes, yet access to comprehensive obesity care remains limited for many. A recent study conducted by a team from Michigan Medicine at the University of Michigan has shed light on the effectiveness of various obesity treatment strategies and highlighted the disparity in access to these interventions.

The study, engaging tens of thousands of individuals diagnosed with obesity, meticulously evaluated the outcomes of diverse weight management interventions, including nutrition counselling, medically supervised meal replacements, anti-obesity medications, and bariatric surgery. The findings revealed that the likelihood of achieving a weight loss of 5% or more within a year varied significantly across the different treatment modalities, ranging from nearly one in four to almost certain success, depending on the specific intervention utilised.

Notably, the research emphasised that a modest weight loss of just 5% can have profound health benefits, underscoring the importance of accessible and effective weight management strategies. However, a critical observation from the study was the underutilisation of available treatments, with a mere fraction of the study population receiving any form of medically endorsed weight management care from their primary healthcare providers.

The investigation revealed a troubling gap in the provision of obesity-related healthcare, with the majority of individuals suffering from obesity not receiving adequate treatment through their regular healthcare channels. This gap is not due to a lack of effective treatments but rather to a systemic failure to integrate these options into standard care practices. The study’s authors advocate for a more proactive approach by primary care clinics, health systems, and insurers to facilitate access to and engagement with effective obesity treatments.

In response to these findings, the University of Michigan has embarked on an innovative programme aimed at transforming obesity care. The Weight Navigation Program, spearheaded by Dina Hafez Griauzde, M.D., M.Sc., and Andrew Kraftson, M.D., seeks to offer personalised treatment paths for patients, leveraging the expertise of board-certified obesity medicine physicians and ongoing support mechanisms, including digital communication tools, to ensure long-term engagement and success.

This initiative not only provides immediate care options for individuals struggling with obesity but also serves as a model for integrating evidence-based weight management strategies into primary care, potentially reshaping the landscape of obesity treatment.

The study conducted by Michigan Medicine highlights the critical need for improved access to and utilisation of weight management treatments in the fight against obesity. By demonstrating the efficacy of various treatment options and pioneering new approaches to care delivery, the research team has laid a foundation for a more inclusive and effective obesity care framework. As healthcare systems and insurers begin to recognise and address the barriers to obesity treatment, there is hope for a future where comprehensive, personalised obesity care is accessible to all who need it.

Hundreds await obesity treatment in Leeds amid service overload

In the bustling city of Leeds, a significant number of individuals find themselves in a prolonged queue for access to specialised obesity management treatments. The Tier 3 Weight Management service, specifically orchestrated to assist adults grappling with severe and intricate forms of obesity, has seen an overwhelming surge in demand, leading to its suspension of new referrals as of July 2023.

Originally established with the ambition to support 250 individuals each year, the service has seen its caseload swell to over 1,000 by the close of December, far surpassing its intended capacity. This escalation has resulted in approximately 660 people currently awaiting their turn for intervention, a situation that the National Health Service (NHS) has acknowledged, pointing these patients towards alternative support mechanisms in the interim.

Operated by the Leeds Community Healthcare NHS Trust (LCH), the programme extends its aid to those with a Body Mass Index (BMI) of 40 or above, or a BMI of 35 coupled with additional health complications, according to the Local Democracy Reporting Service. Yet, a briefing prepared for the LCH’s board meeting highlighted a continuous and significant overrun of the waiting list beyond the service’s contractual agreements.

Amidst considerations for the service’s reconfiguration, novel treatment options, including injectable medications aimed at weight reduction, have been proposed. Nevertheless, apprehensions regarding the fiscal repercussions of such expansive implementation have been raised by the West Yorkshire Integrated Care Board (ICB), the body responsible for commissioning this service. The current strategy involves a cautious, staged reintroduction of services.

To alleviate some of the pressure, the ICB allocated an additional £192,000 to bolster the Tier 3 programme, although this injection of funds is set to conclude by April. Decisions regarding further financial commitments to the service, which engages with patients over a period of 12 to 18 months, are anticipated by the end of March.

The uniqueness of Leeds’ offering in the landscape of UK healthcare has been underscored by a spokesperson, who noted, “Many areas across the UK do not have access to a specialist service like the offer we have available in Leeds.” The statement further reflected on the financial dilemmas facing the healthcare system, emphasising the need to judiciously balance further investments against other obligatory responsibilities.

Plans are underway to enhance the service through the introduction of digital treatment options, augmented mental health support, expanded educational resources, and a reevaluation of the criteria for referral, aiming to provide a more comprehensive and accessible approach to obesity management amidst challenging fiscal constraints.